ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

09 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates

06 نوفمبر 2023 16:10:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

02 نوفمبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile

21 أكتوبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023

17 أكتوبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 أكتوبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

20 سبتمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

30 أغسطس 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

10 أغسطس 2023 16:05:03 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 أغسطس 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

26 يونيو 2023 08:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 يونيو 2023 16:15:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

31 مايو 2023 16:10:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates

08 مايو 2023 16:05:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 مايو 2023 16:15:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 أبريل 2023 16:30:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 أبريل 2023 16:15:00 بحسب Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire